Cytokinetics (CYTK)
Your Dashboard
Displaying CYTK Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 0.926M
- Accounts Receivable 0.083M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 0.0852
- Beneish M-Score Pro
- Beta Pro
- Book Value 42.01M
- Book Value per Share 0.55
- Capital Expenditures 0.013M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing 2.667M
- Cash Financing TTM 24.53M
- Cash Investing 5.052M
- Cash Investing TTM 19.28M
- Cash Operations -8.737M
- Cash Operations TTM -41.45M
- Cash and Equivalents 17.82M
- Cash and ST Investments 43.08M
- Current Ratio 10.12
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.00
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share -0.13
- Earnings Per Share Growth
- Earnings Per Share TTM -0.67
- Earnings Yield -72.04%
- Effective Tax Rate TTM Pro
- Enterprise Value 53.22M
- Expenses 11.75M
- Expenses TTM 53.99M
- Free Cash Flow -8.75M
- Free Cash Flow TTM -41.73M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM 5.057M
- Income from Cont. Ops Pro
- Interest Expense 0.00
- Interest Income 0.012M
- Inventories
- KZ Index Pro
- Liabilities 4.524M
- Long Term Debt 0.00
- Market Cap 71.03M
- Net Income -9.928M
- Net Income TTM -48.93M
- Net PP&E 1.132M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 0.93
- Price / Book Value 1.691
- Price / Sales Ratio 14.05
- Price / Tangible Book Value Pro
- Profit Margin -545.5%
- R&D Expense 8.745M
- Receivables Turnover
- Retained Earnings -418.44M
- Retained Earnings Growth
- Return on Assets -81.85%
- Return on Equity -89.57%
- Return on Invested Capital Pro
- Revenue Growth 138.5%
- Revenue Per Share TTM 0.0662
- Revenues 1.82M
- Revenues TTM 5.057M
- SG&A Expense 3.056M
- Shareholders Equity 42.01M
- Shares Outstanding 76.38M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 46.53M
- Total Return Price 0.93
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these CYTK related companies
CYTK News
$CYTK forms bearish "Continuation Diamond" chart pattern. http://stks.co/3aqN
about 28 days ago by RecogniaEvents
about 28 days ago by RecogniaEvents
@Jamtrades @seekingalpha when they use the term encouiraging it usually means its crap $CYTK
about 33 days ago by lieberlanz
about 33 days ago by lieberlanz
Cytokinetics (CYTK) Proposed Muscle Troponin Activator Now on FDA's Fast Track
Apr 19, 8:53AM Street Insider
Apr 19, 8:53AM Street Insider
$CYTK forms bearish "Head and Shoulders Top" chart pattern. http://stks.co/3IOW
about 48 days ago by RecogniaEvents
about 48 days ago by RecogniaEvents
$CYTK filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3BjU
about 56 days ago by MarketBrief
about 56 days ago by MarketBrief
Cytokinetics to Present at the Eleventh Annual Needham Life Sciences Conference
Mar 27, 4:13PM Marketwire
Mar 27, 4:13PM Marketwire
@ChiBullsTrader @ChillzTrading Agree! May add position for that event; already have $CYTK for the same conference.
about 68 days ago by Chilltill
about 68 days ago by Chilltill
$CYTK forms bullish "Diamond Bottom" chart pattern. http://stks.co/2kad
about 81 days ago by RecogniaEvents
about 81 days ago by RecogniaEvents
Cytokinetics, Inc. (CYTK) Posts Q4 Loss of 16c/Share; Guides FY12 Revs
Feb 02, 4:13PM Street Insider
Feb 02, 4:13PM Street Insider
Cytokinetics, Incorporated Reports Fourth Quarter and Year End Highlights and 2011 Financial Results
Feb 02, 4:00PM Marketwire
Feb 02, 4:00PM Marketwire
Cytokinetics to Announce Fourth Quarter and Year End Results on February 2, 2012
Jan 26, 4:00PM Marketwire
Jan 26, 4:00PM Marketwire
Cytokinetics (CYTK) Reports Positive CK-2017357 Phase II, Part A Dat in ALS Patients
Nov 30, 7:32AM Street Insider
Nov 30, 7:32AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CYTK | 0.93 | +0.02 | +2.20% | 71.03M |
| CYT | 60.59 | -0.40 | -0.66% | 2.777B |
| CYS | 13.80 | -0.06 | -0.43% | 1.541B |
| CYOU | 21.81 | +0.12 | +0.55% | 1.145B |
| CYN | 50.25 | -0.29 | -0.57% | 2.674B |
| CYMI | 53.30 | -0.08 | -0.15% | 1.643B |
| CYH | 22.66 | +0.28 | +1.25% | 2.075B |
| CYE | 7.55 | +0.05 | +0.67% | |
| CYCC | 0.5124 | -0.02 | -3.32% | 27.79M |
| CYBI | 1.761 | -0.03 | -1.62% | 30.15M |
